Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory CNS disease that
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …

Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …

The understanding of neuromyelitis optica spectrum disorder (NMOSD) has evolved
substantially since its initial description over a century ago. The discovery in 2004 of a …

Importance Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune
astrocytopathies characterized by predominant involvement of the optic nerves and spinal …

Objective To compare response to rituximab (RTX) between adult patients positive for
myelin oligodendrocyte glycoprotein (MOG) and aquaporin‐4 (AQP4) antibodies. Methods …

Neuromyelitis optica spectrum disorder (NMOSD) often follows a relapsing course. As
disability in NMOSD is attack-related, effective treatments are needed. We aimed to compare …

This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …

Background Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) are related to
several acquired demyelinating syndromes in adults, but the therapeutic approach is …

Objective To analyse predictors for relapses and number of attacks under different
immunotherapies in patients with neuromyelitis optica spectrum disorder (NMOSD). Design …

Background During the last two decades, neuromyelitis optica spectrum disorder (NMOSD)
has undergone important changes, with new diagnostic markers and criteria, better …